Serum Lp(a) lipoprotein levels in patients with coronary artery disease and the influence of long-term n-3 fatty acid supplementation

References

• Berg K. A new serum type system in man—the Lp system. Acta Path Microbiol Scand 1963; 59: 369–82
   PubMedGoogle Scholar
• Berg K, Dahlén G, Frick M H. Lp(a) lipoprotein and pre-β1-lipoprotein in patients with coronary heart disease. Clin Genet 1974; 6: 230–5
   PubMed Web of Science ®Google Scholar
• Dahlén G H, Guyton J R, Attar M, Farmer J A, Kautz J A, Gotto A M. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758–65
   PubMed Web of Science ®Google Scholar
• Rhoads G R, Dahlén G, Berg K, Morton N E, Dannenberg A L. Lp(a) lipoprotein as a risk factor for myocardial infarction. J Am Med Assoc 1986; 256: 2540–4
   PubMed Web of Science ®Google Scholar
• Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. Br Med J 1990; 301: 1248–51
   PubMed Web of Science ®Google Scholar
• Genest J, Jenner J L, McNamara J R, Ordovas J M, Silberman S R, Wilson PWF. Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease. Am J Cardiol 1991; 67: 1039–45
   PubMed Web of Science ®Google Scholar
• Mölgaard J, Klausen I C, Lassvik C, Færgeman O, Gerdes L V, Olsson A G. Significant association between low-molecular-weight apolipoprotein (a) isoforms and intermittant claudication. Arterioscler Thromb 1992; 12: 895–901
   PubMedGoogle Scholar
• Schreiner P J, Morrisett J D, Sharrett A R, Patsch W, Tyroler H A, Wu K. Lipoprotein(a) as a risk factor for preclinical atherosclerosis. Arterioscler Thromb 1993; 13: 826–33
   PubMedGoogle Scholar
• Jauhiainen M, Koskinen P, Ehnholm C, Frick M H, Mänttäri M, Manninen V. Lipoprotein(a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991; 89: 59–67
   PubMed Web of Science ®Google Scholar
• Ridker P M, Hennekens C H, Stampfer M J. A prospective study of lipoprotein (a) and the risk of myocardial infarction. J Am Med Assoc 1993; 270: 2195–9
   PubMed Web of Science ®Google Scholar
• Loscalzo J. Lipoprotein (a). A unique risk factor for atherothrombotic disease. Arteriosclerosis 1990; 10: 672–9
   Google Scholar
• Miles L A, Plow E F. Lp(a): An interloper into the fibrinolytic system. Thromb Haemostas 1990; 63: 331–5
   Google Scholar
• Berg K, Mohr J. Genetics of the Lp system. Acta Genet 1963; 13: 349–60
   Google Scholar
• Morton N E, Berg K, Dahlén G, Ferrell R E, Rhoads G G. Genetics of the Lp lipoprotein in Japanese-Americans. Genet Epidemiol 1985; 2: 113–21
   Google Scholar
• Berg K. Genetics of atherogenic Lp(a) lipoprotein. From phenotype to gene in common disorders, K Berg, N Retterstøl, S Refsum. Munksgaard, Copenhagen 1990; 138–62
   Google Scholar
• Vessby B, Kostner G, Lithell H, Thomis J. Diverging effects of cholestyramine on apolipoprotein B and lipoprotein(a). Atherosclerosis 1982; 44: 61–71
   PubMed Web of Science ®Google Scholar
• Kostner G M, Gavish D, Leopold B, Bolzano K, Weintraub M S, Breslow J L. HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation 1989; 80: 1313–9
   PubMed Web of Science ®Google Scholar
• Gries A, Malle E, Wurm H, Kostner G M. Influence of dietary fish oils on plasma Lp(a) levels. Thromb Res 1990; 58: 667–8
   Google Scholar
• Berg Schmidt E, Klausen I C, Kristensen S D, Lervang H-H, Færgeman O, Dyerberg J. The effect of n-3 polyunsaturated fatty acids on Lp(a). Clin Chim Acta 1991; 198: 271–7
   Google Scholar
• Malle E, Sattler W, Prenner E, Leis H J, Hermetter A, Gries A. Effects of dietary fish oil supplementation on platelet aggregability and platelet membrane fluidity in normolipemic subjects with and without high plasma Lp(a) concentrations. Atherosclerosis 1991; 88: 193–201
   PubMed Web of Science ®Google Scholar
• Beil F U, Terres W, Orgass M, Greten H. Dietary fish oil lowers lipoprotein (a) in primary hypertriglyceridemia. Atherosclerosis 1991; 90: 95–7
   PubMed Web of Science ®Google Scholar
• Eritsland J, Arnesen H, Grønseth K, Fjeld N B, Abdelnoor M. Effect of supplementation with n-3 fatty acids on graft patency in patients undergoing coronary artery bypass operation. Results from the SHOT study [abstract]. Eur Heart J 1994; 15 Suppl: 29
   Google Scholar
• Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Berg K. Inherited lipoprotein variation and atherosclerotic disease. The biochemistry of atherosclerosis, A M Scanu, R W Wissler, G S Getz. Marcel Dekker, New York 1979; 419–90
   Google Scholar
• Berg K. Lp(a) lipoprotein: an important genetic risk factor for atherosclerosis. Molecular genetics and coronary artery disease. Candidate genes and processes in atherosclerosis. Monogr Hum Genet, A J Lusis, J I Rotter, R S Sparkes. Karger, Basle 1992; 189–207
   Google Scholar
• Eritsland J, Seljeflot I, Abdelnoor M, Arnesen H. Long-term influence of omega-3 fatty acids on fibrinolysis, fibrinogen, and serum lipids. Fibrinolysis 1994; 8: 120–5
   Google Scholar
• Clauss A. Gerinnungsphysiologische Schnell-metode zur Bestimmung des Fibrinogens. Acta Haematol (Basle) 1957; 17: 237–46
   PubMedGoogle Scholar
• Rothman K J. Modern Epidemiology. Little Brown, Boston 1986; 289–95
   Google Scholar
• BMDP Statistical Software. Berkeley, Los Angeles 1990
   Google Scholar
• Armstrong V W, Cremer P, Eberle E, Manke A, Schulze F, Wieland H. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Atherosclerosis 1986; 62: 249–57
   PubMed Web of Science ®Google Scholar
• Alessi M C, Parra H J, Joly P, Vu-Dac N, Bard J M, Fruchart J C. The increased plasma Lp(a): B lipoprotein particle concentration in angina pectoris is not associated with hypofibrinolysis. Clin Chim Acta 1990; 188: 119–28
   Google Scholar
• McLean J W, Tomlinson J E, Kuang W-J, Eaton D L, Chen E Y, Fless G M. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 1987; 300: 132–7
   Web of Science ®Google Scholar
• Miles L A, Fless G M, Levin E G, Scanu A M, Plow E F. A potential basis for the thrombotic risks associated with lipoprotein (a). Nature 1989; 339: 301–5
   PubMed Web of Science ®Google Scholar
• Hajjar K A, Gavish D, Breslow J L, Nachman R L. Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989; 339: 303–5
   PubMed Web of Science ®Google Scholar
• Garcia Frade L J, Alvarez J J, Rayo I, Torrado M C, Lasuncion M A, Garcia Avello A. Fibrinolytic parameters and lipoprotein (a) levels in plasma of patients with coronary artery disease. Thromb Res 1991; 63: 407–18
   Google Scholar
• Halvorsen S, Skjønsberg O H, Berg K, Ruyter R, Godal H C. Does Lp(a) lipoprotein inhibit the fibrinolytic system. Thromb Res 1992; 68: 223–32
   Google Scholar
• Sundell I B, Nilsson T K, Hallmans G, Hellsten G, Dahlén G H. Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a North Swedish population. Atherosclerosis 1989; 80: 9–16
   Google Scholar
• Heinrich J, Sandkamp M, Kokott R, Schulte H, Assmann G. Relationship of lipoprotein (a) to variables of coagulation and fibrinolysis in a healthy population. Clin Chem 1991; 37: 1950–4
   PubMed Web of Science ®Google Scholar
• Glueck C J, Glueck H I, Tracy T, Speirs J, McCray C, Stroop D. Relationships between lipoprotein (a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer. Metabolism 1993; 42: 236–46
   PubMed Web of Science ®Google Scholar
• Slunga L, Asplund K, Johnson O, Dahlén G H. Lipoprotein (a) in a randomly selected 25–64 year old population: the Northern Sweden MONICA study. J Clin Epidemiol 1993; 46: 617–24
   PubMed Web of Science ®Google Scholar